Advanced search
Publication Cover
Leukemia & Lymphoma Volume 58, 2017 - Issue 6
Submit an article Journal homepage
747
Views
41
CrossRef citations to date
0
Altmetric
Letters to the Editor

Spectrum of autoimmune diseases and systemic inflammatory syndromes in patients with chronic myelomonocytic leukemia

Mohammad Faizan ZahidDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA;
,
Daniela BarracoDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA;
,
Terra L. LashoDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA;
,
Christy FinkeDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA;
,
Rhett P. KetterlingDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA
,
Naseema GangatDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA;
,
Curtis A. HansonDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA
,
Ayalew TefferiDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA;
&
Mrinal M. PatnaikDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA; Correspondence[email protected]
 show all
Pages 1488-1493 | Received 05 Sep 2016, Accepted 28 Sep 2016, Published online: 14 Oct 2016

References

  • Patnaik MM, Wassie EA, Padron E, et al. Chronic myelomonocytic leukemia in younger patients: molecular and cytogenetic predictors of survival and treatment outcome. Blood Cancer J. 2015;4:e270.
  • Giannouli S, Voulgarelis M, Zintzaras E, et al. Autoimmune phenomena in myelodysplastic syndromes: a 4-yr prospective study. Rheumatology (Oxford). 2004;43:626–632.
  • Grignano E, Mekinian A, Braun T, et al. Autoimmune and inflammatory diseases associated with chronic myelomonocytic leukemia: a series of 26 cases and literature review. Leuk Res. 2016;47:136–141.
  • Mekinian A, Grignano E, Braun T, et al. Systemic inflammatory and autoimmune manifestations associated with myelodysplastic syndromes and chronic myelomonocytic leukemia: a French multicentre retrospective study. Rheumatology. 2016;55:291–300.
  • Peker D, Padron E, Bennett JM, et al. A close association of autoimmune-mediated processes and autoimmune disorders with chronic myelomonocytic leukemia: observation from a single institution. Acta Haematol. 2014;133:249–256.
  • Vardiman JW, Thiele J, Arber DA. The 2008 revision of the WHO classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood. 2009;11:937–951.
  • Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia. Blood. 2016;127:2391–2405.
  • Shoenfeld Y, Cervera R, Gershwin ME, Diagnostic criteria in autoimmune diseases. Berlin, Germany: Springer Science & Business Media; 2010.
  • Patnaik MM, Padron E, LaBorde RR, et al. Mayo prognostic model for WHO-defined chronic myelomonocytic leukemia: ASXL1 and spliceosome component mutations and outcomes. Leukemia. 2013;27:1504–1510.
  • Fraison J-B, Mekinian A, Grignano E, et al. Efficacy of Azacitidine in autoimmune and inflammatory disorders associated with myelodysplastic syndromes and chronic myelomonocytic leukemia. Leuk Res. 2016;43:13–17.
  • Anderson LA, Pfeiffer RM, Landgren O, et al. Risks of myeloid malignancies in patients with autoimmune conditions. Br J Cancer. 2009;100:822–828.
  • Braun T, Fenaux P. Myelodysplastic syndromes (MDS) and autoimmune disorders (AD): cause or consequence? Best Pract Res Clin Haematol. 2013;26:327–336.
  • De Hollanda A, Beucher A, Henrion D, et al. Systemic and immune manifestations in myelodysplasia: a multicenter retrospective study. Arthritis Care Res (Hoboken). 2011;63:1188–1194.
  • Fain O, Braun T, Stirnemann J, et al. Systemic and autoimmune manifestations in myelodysplastic syndromes. Rev Med Interne. 2011;32:552–559.
  • Giannouli S, Kanellopoulou T, Voulgarelis M. Myelody-splasia and autoimmunity. Curr Opin Rheumatol. 2012;24:97–102.
  • Patnaik MM, Tefferi A. Chronic myelomonocytic leukemia: molecularly contaminated, but not defined. Leuk Lymphoma. 2016;57:1751–1752.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.